Skip to main content

UBS structures second Alpine risk capacity ‘enhancer’

UBS has enhanced the credit risk capacity in its derivatives trading book by E1.5 billion, through an innovative managed securitisation issued in early April. The so-called Alpine II structure, based on the description of its reference pool and the ratings applicable, could save the bank between 20% and 30% of the cost of using single-name credit default swaps. It is aimed at freeing UBS’s credit limits to enable the bank to trade more derivatives volumes with key business clients, the bank claims.

graph1-jpg
The deal draws on UBS’s experience in developing Alpine I, conceived by the bank in mid-1999. That 10-year amortised transaction, which closed in December 2000, also took a portfolio of the bank’s investment-grade credit counterparty risk from its derivatives trading book. This was structured into different risk/reward tranches that were sold to investors. That issue transferred $750 million

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Want to know what’s included in our free membership? Click here

The wild world of credit models

The Covid-19 pandemic has induced a kind of schizophrenia in loan-loss models. When the pandemic hit, banks overprovisioned for credit losses on the assumption that the economy would head south. But when government stimulus packages put wads of cash in…

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here